Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Gains from Investment Securities (2020 - 2025)

RxSight (RXST) has disclosed Gains from Investment Securities for 6 consecutive years, with -$3000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$3000.0, compared with a TTM value of $32000.0 through Dec 2025, down 5.88%, and an annual FY2025 reading of $32000.0, down 99.46% over the prior year.
  • Gains from Investment Securities was -$3000.0 for Q4 2025 at RxSight, down from $3000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.7 million in Q4 2021 and bottomed at -$2.7 million in Q3 2021.
  • Average Gains from Investment Securities over 5 years is $7764.7, with a median of $9000.0 recorded in 2021.
  • The sharpest move saw Gains from Investment Securities crashed 640.0% in 2022, then soared 1633.33% in 2023.
  • Year by year, Gains from Investment Securities stood at $2.7 million in 2021, then plummeted by 100.11% to -$3000.0 in 2022, then skyrocketed by 1633.33% to $46000.0 in 2023, then plummeted by 78.26% to $10000.0 in 2024, then crashed by 130.0% to -$3000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for RXST at -$3000.0 in Q4 2025, $3000.0 in Q3 2025, and $19000.0 in Q2 2025.